-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol.pdf
September 13, 2024 - Food and Drug Administration (FDA) has commissioned a rapid review on the
misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse
as: “taking a medication in a manner or … Drug Alcohol Depend.
2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug
Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh]
OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance
Abuse, Oral
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
May 29, 2025 - Harms of tricyclic antidepressants versus placebo
Author, Year Quality Pain Population Drug Class Drug … Harms of pregabalin versus placebo
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of pregabalin versus amitriptyline
Author, Year Quality Pain Population Drug Class Drug Assessment … Harms of pregabalin CR versus IR
Author, Year Quality Pain Population Drug Class Drug Assessment Time … Harms of cannabis versus placebo
Author, Year Quality Pain Population Drug Assessment Time (Wk) Time
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/research
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/policymaker
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/consumer
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/clinician
-
effectivehealthcare.ahrq.gov/products/alcohol-misuse-drug-therapy/espanol
-
effectivehealthcare.ahrq.gov/sites/default/files/mcda-ijzerman.pdf
January 01, 2011 - pressure
3 US$
Drug C
partial relief
No adverse
events
5 US$
Slide … use) of a drug to its impact of treatment (e.g., drug requires complex dosing schedule
and monitoring … use) of a drug to its impact of treatment (e.g., drug requires complex dosing
schedule and monitoring … This screen is titled: Goal: Select the best drug treatment. … Clinical Benefit (symptom relieve due drug use) Impact of Treatment (e.g. drug
requires complex dosing
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/misuse-prescription-protocol-amendment.pdf
November 26, 2024 - Food and Drug Administration (FDA) has commissioned a rapid review on the
misuse of attention-deficit … The National Institute on Drug Abuse (NIDA) describes misuse
as: “taking a medication in a manner or … Drug Alcohol Depend.
2020 Apr 1;209:107907. doi: 10.1016/j.drugalcdep.2020.107907. … Misuse"[Mesh] OR "Drug Misuse"[Mesh] OR "Prescription Drug
Diversion"[Mesh] OR "Substance Abuse, Oral … Misuse"[Mesh]
OR "Drug Misuse"[Mesh] OR "Prescription Drug Diversion"[Mesh] OR "Substance
Abuse, Oral
-
effectivehealthcare.ahrq.gov/sites/default/files/communicating_risk_hickam.ppt
December 01, 2006 - practice & research
Morning Presentations
Innovative Methods of Communicating Harms and Benefits of Drug
-
effectivehealthcare.ahrq.gov/get-involved/nominated-topics/for-patients-with-pku-there-is-now-a-pharmaceutical-drug-to-treat-this-condition-in-the-past-is-was-treated-by-medical-foods-that-eliminated-the-harmful-substance-phenylalanine-the-cost-of-the-new-drug-is-70k-year-the-cost-t
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs4-computerized-cds-protocol.pdf
May 08, 2023 - What is the frequency and severity of medication errors and adverse drug events?
2. … indicators have been used to examine the frequency
and severity of medication errors and adverse drug … related to a drug”.1, 2 Adverse drug events are a leading type of
healthcare-related harm, accounting … Medication Errors and Adverse
Drug Events. … Adverse drug events in ambulatory care.
-
effectivehealthcare.ahrq.gov/sites/default/files/s131.pdf
October 01, 2007 - Prevalent users of a drug have by definition persisted in
their drug use, similar to the concept of survivor … to the drug). … likely to use the same drug again. … subjects who did not use any drug of this class. … of a drug in a given patient.
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - The drug has been granted orphan drug designation. … Available:
http://www.vrtx.com/current-projects/drug-
candidates/vx-770.html.
3. … Food and Drug Administration (FDA);
2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html
http://investors.vrtx.com/releasedetail.cfm? … Oral treprostinil new drug application accepted
by FDA for review. [internet].
-
effectivehealthcare.ahrq.gov/sites/default/files/s29.pdf
October 01, 2007 - 1 study drug was a newer drug (“on the market for 1 yr”)? … Compare drug to nondrug alternative
(vs. drug-drug comparison)
Possibly acceptable if the treatments … Newer drug (1 drug on the market for
only a year vs. both drugs on the
market for “quite a while”)
More … “You
are making one drug your preferred drug; does that also
mean you are going to take the other drug … and make it your
nonpreferred drug?
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - Ivacaftor in combination with another experimental
CF drug, VX-809, has also been shown to improve … Even for patients with prescription drug coverage, copayments are expected to be
significant. … Available: http://www.vrtx.com/current-
projects/drug-candidates/vx-770.html.
3. … Food
and Drug Administration (FDA); 2012 Jan 31
[accessed 2012 Feb 22]. [2 p]. … /current-projects/drug-candidates/vx-770.html
http://investors.vrtx.com/releasedetail.cfm?
-
effectivehealthcare.ahrq.gov/sites/default/files/s81.pdf
October 01, 2007 - for drug-induced delirium/
psychosis. … In
contrast, few ICD-9-CM codes specifically describe drug
exposure. … A wide variety of commonly used drug classes cause delir-
ium. … Aggregate variables of ICD-9-CM codes that indicated drug-
TABLE 1. … Drug Saf. 1999;20:109–117.
14. Hurdle JF, Weir CR, Roth B, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
December 15, 2010 - and Drug-Dietary Supplement Interactions:
In the clinical setting, drug-supplement interactions are … more difficult to interpret than drug-drug
interactions for a variety of reasons. … Due to U.S. drug regulatory policy, much more research and
data are available describing drug-drug interactions … b. . . .cause alterations in cellular drug-transport mechanisms (e.g., drug-transport proteins)? … of the mechanisms of absorption and distribution of an administered drug, the rate at which a
drug
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
April 01, 2025 - * OR drug* OR contrast OR chemo* OR heparin OR
drug* OR medicin* OR medication*OR pharma* OR prescription … Drug tendering: Drug supply and shortage
implications for the uptake of biosimilars. … Ashp guidelines on
managing drug product shortages. … safety
partnership drug checking program. … drug supply chain.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - therapy and ignoring the duration of drug use. … For example, some propensity
scores predict a combination of incident drug use, persistence with a drug … newly
marketed drug. … or class be compared with incident users of another drug or class? … Pharmacoepidemiol Drug Safety
2007;16:329-36.
4. Ray WA.